Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$1.55M-$1.93M+25.5%-$2.59M-64.4%-$1.57M-163%
$1.13M+11.2%$1.02M+0.8%$1.01M+0.4%$1.01M-0.8%$1.01M+185%
$1.52M+35.1%$1.12M+2.9%$1.09M-47.9%$2.1M+74.7%$1.2M+53.5%
$7.41M$12.03M+51.1%$7.96M+281%$2.09M
$75K+53.1%$49K-82.7%$284K-$0-$0-100%
-$0-$0-$0-$0-100%
-$15.08M-30,665%-$49K+82.7%-$284K$0$0+100%
$1.39M+230%$421K$394K-98.8%
-$6.28M$11.74M+47.5%$7.96M+220%$2.48M+147%
$7.33M$11.74M+47.5%$7.96M+281%$2.09M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Eton Pharmaceuticals, Inc. generate?
Eton Pharmaceuticals, Inc. (ETON) generated $29.5M in operating cash flow over the trailing twelve months.
What is Eton Pharmaceuticals, Inc.'s free cash flow?
After $408.0K of capital expenditures, Eton Pharmaceuticals, Inc.'s free cash flow was $29.1M over the trailing twelve months, up 1588.2% year over year.
Where does Eton Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.